Randomized Clinical Comparison of Biomatrix Flex and Resolute Integrity Coronary Stents in Non-selected Patients With Ischemic Heart Disease The SORT OUT VI Study*

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 May 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Umirolimus (Primary) ; Zotarolimus (Primary)
Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
Focus Therapeutic Use
Acronyms SORT OUT VI; SORT-OUT VI

02 Nov 2017 Results assessing 3-year clinical outcomes in patients with ACS (n=521), presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
02 Nov 2017 Results of substudy presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
30 Aug 2017 Results of pooled analysis of SORT OUT III- V studies presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com